Kevin Harrington, Professor in Biological Cancer Therapies at the Institute of Cancer Research, shared a post on LinkedIn:
“I have just returned from the Silver Jubilee 25th Foundation of Head and Neck Oncology (FHNO) meeting in Bangalore, India. The meeting had a strong theme of global engagement, while remaining true to its core themes of improving outcomes for Indian patients with head and neck cancers.
As with other trips to India, I was hugely impressed by the quality of the clinical teams from across India who deal with rates of head and neck cancer that we simply do not experience in the UK and and elsewhere in the West. The presentations were wide-ranging across the entire spectrum of clinical care and laboratory science and of a very high standard.
I was fortunate enough to be part of a large contingent of UK head and neck specialists, including a delegation from The British Association of Head and Neck Oncology (led by Professors Chris Nutting [current BAHNO President] and Vin Paleri [past BAHNO President]), senior representation from the team in Liverpool (Professors Terry Jones, Richard Shaw and Keith Hunter) and experts from Newcastle [Mr James O’Hara and Laura-Jayne Watson] and Exeter [Mr Ben Rymer]. It was clear that there exist great opportunities for future collaboration between UK and Indian colleagues with the prospect of significant benefits for large numbers of patients.
I would also like to pay tribute to the Organising Committee who did such an outstanding job in designing a programme that was truly at the cutting edge. It would be impossible to mention all of those who were integral to the success of the meeting (and apologies to any I omit), but I would like personally to thank Dr Krishnappa Ramachandrappa, Dr Samskruthi Murthy, Dr Sreeram M.P and Dr Vikram Kekatpure for inviting me to the meeting and to ensuring that everything was beautifully organised.
In addition to wonderful scientific discourse, we also enjoyed amazing cultural experiences including traditional music, dance and drumming.”
More posts featuring Kevin Harrington on OncoDaily.
